Omkar Speciality Chemicals Schedules Monitoring Committee Meeting for April 15, 2026
Omkar Speciality Chemicals Limited has scheduled a monitoring committee meeting for April 15th, 2026, under SEBI Regulation 29 compliance. The meeting will address critical restructuring matters including extinguishment of existing equity shares, issuance of 50,00,000 new shares worth INR 5,00,00,000 on private placement basis, appointment of CFO and Company Secretary, and review of CIRP costs and statutory compliances.

*this image is generated using AI for illustrative purposes only.
Omkar Speciality Chemicals Limited has intimated stock exchanges about its monitoring committee meeting scheduled for April 15th, 2026, in compliance with Regulation 29 of SEBI listing obligations. The company, which entered Corporate Insolvency Resolution Process (CIRP) on December 5th, 2022, will address several critical corporate restructuring matters under the supervision of Chairperson Mr. Ajit Kumar, the erstwhile Resolution Professional.
Key Agenda Items
The monitoring committee meeting will consider multiple significant proposals that reflect the company's ongoing restructuring process under the approved resolution plan. The formal intimation was sent to both BSE Limited and National Stock Exchange of India Limited on April 7th, 2026.
Equity Share Restructuring
The committee will determine record dates for extinguishment and cancellation of existing equity shares in accordance with the approved scheme:
| Share Category: | Details |
|---|---|
| Promoter Shares: | Entire equity shares of INR 10 each, fully paid up |
| Public Shareholder Shares: | Entire equity shares of INR 10 each, fully paid up |
| Action: | Complete extinguishment/cancellation |
New Share Issuance
A major agenda item involves approving the issuance of new equity shares under the resolution plan:
| Parameter: | Details |
|---|---|
| Number of Shares: | 50,00,000 equity shares |
| Face Value: | INR 10 each |
| Issue Price: | At par |
| Total Consideration: | INR 5,00,00,000 |
| Issuance Method: | Private Placement Basis |
Financial and Operational Matters
The meeting will address several operational aspects crucial for the company's revival. The committee will approve borrowing arrangements through loan agreements without conversion options into securities. Additionally, they will consider opening an equity subscription account to facilitate the new share issuance process.
The agenda includes reviewing statutory and contractual compliances, along with adjustment and reimbursement of CIRP costs, including additional liabilities and utilization of interest earned on Performance Bank Guarantee Fixed Deposit Receipts.
Key Appointments
The committee will consider appointing key management personnel to strengthen the company's operational framework:
| Position: | Appointee Details |
|---|---|
| Chief Financial Officer: | Mr. Mahendra Kumar Jain (PAN: AYHPJ9945Q) |
| Company Secretary & Compliance Officer: | Mr. Kuldeep Menaria (Membership No. ACS: 68041) |
Corporate Background
Omkar Speciality Chemicals Limited, incorporated with CIN L24110MH2005PLC151589, is registered in Badlapur, Maharashtra. The company entered CIRP through an order dated December 5th, 2022, under case IA 1521/2022 In C.P. (IB)/1738(MB)2017. The monitoring committee is chaired by Mr. Ajit Kumar, the erstwhile Resolution Professional, who continues to oversee the company's restructuring process from his office at Ocus Quantum, Sector 51, Gurugram.
The meeting represents a significant step in the company's resolution process, with the committee set to discuss future action plans for the organization's revival and operational restart.
Historical Stock Returns for Omkar Speciality Chemicals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +3.30% | +10.33% | -0.68% | -19.63% | -23.96% | -44.56% |
What impact will the complete extinguishment of existing equity shares have on current shareholders' recovery prospects?
How will the new private placement of 50 crore rupees be utilized to revive the company's specialty chemicals operations?
What are the key operational milestones and timeline for Omkar's business restart following this restructuring?


























